BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 14673743)

  • 41. [Prognostic factors during coma due to acute hepatic atrophy].
    Caroli J; Opolon P; Scotto J; Hadchouel P; Thomas M; Lageron A
    Presse Med (1893); 1971 Feb; 79(11):463-6. PubMed ID: 5555633
    [No Abstract]   [Full Text] [Related]  

  • 42. Is flumazenil an alternative for the treatment of hepatic encephalopathy?
    Reyes D; Barrera F
    Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of hepatic encephalopathy.
    Córdoba J; Blei AT
    Am J Gastroenterol; 1997 Sep; 92(9):1429-39. PubMed ID: 9317058
    [No Abstract]   [Full Text] [Related]  

  • 45. Differential effects of ammonia on the benzodiazepine modulatory site on the GABA-A receptor complex of human brain.
    Ahboucha S; Araqi F; Layrargues GP; Butterworth RF
    Neurochem Int; 2005 Jul; 47(1-2):58-63. PubMed ID: 15913842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic Encephalopathy.
    Gow AG
    Vet Clin North Am Small Anim Pract; 2017 May; 47(3):585-599. PubMed ID: 28069286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Amnoniacal detoxication and cerearal metabolism].
    Nordmann R
    Cah Coll Med Hop Paris; 1967 Mar; 8(3):185-90. PubMed ID: 5614605
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hepatic encephalopathy. L-ornithine-L-aspartate stimulate detoxification capacity of the liver].
    Ameri AA
    MMW Fortschr Med; 2010 Jun; 152(22):42-3. PubMed ID: 20590033
    [No Abstract]   [Full Text] [Related]  

  • 49. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.
    Córdoba J; López-Hellín J; Planas M; Sabín P; Sanpedro F; Castro F; Esteban R; Guardia J
    J Hepatol; 2004 Jul; 41(1):38-43. PubMed ID: 15246205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapy of hyperammonemia: effect of a preparation arginine pyrrolidonecarboxylate, taurine, vitamin B6 and citric acid].
    Verzetti G; Emanuelli G; Montagnani M
    Clin Ter; 1972 Mar; 60(5):429-38. PubMed ID: 5038775
    [No Abstract]   [Full Text] [Related]  

  • 51. [The use of flumazenil in the treatment of hepatic encephalopathy secondary to acute liver failure. A report of 2 cases].
    Díaz de León-Ponce M; Eid-Lidt G; Castañón-González JA; Deseaño-Estudillo JL; Reyes B
    Gac Med Mex; 1993; 129(5):347-50. PubMed ID: 7926421
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hepatic encephalopathy. Early therapy is most important!].
    MMW Fortschr Med; 2014 Nov; 156(19):28. PubMed ID: 25510011
    [No Abstract]   [Full Text] [Related]  

  • 53. [Ornithine aspartate in hepatic encephalopathy: an established new therapeutic approach. Overview and results of current randomized studies].
    Krüger B; Held C; Kircheis G
    Z Arztl Fortbild (Jena); 1994 Sep; 88(9):673-9. PubMed ID: 7975752
    [No Abstract]   [Full Text] [Related]  

  • 54. [Ammoniemic intoxication in a subject with liver disease].
    Secchi GC; Rezzonico A
    Arch Ital Mal Appar Dig; 1968; 35(2):99-122. PubMed ID: 5706410
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain].
    MMW Fortschr Med; 2004 Jan; 146(5):51. PubMed ID: 15035428
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hepatic depuration with heterologous liver. Physiopathological presuppositions, indications and metabolic and hemodynamic characteristics of the experimental preparation].
    Rossotto P; Motta G; Guberti A; Azzena GF; Tabone E
    Minerva Med; 1969 Mar; 60(24):1075-94. PubMed ID: 5781337
    [No Abstract]   [Full Text] [Related]  

  • 57. [Because hepatic encephalopathy is a frequent contributing factor. Patients with liver cirrhosis are poorer drivers].
    MMW Fortschr Med; 2003 Nov; 145(47):61. PubMed ID: 14725039
    [No Abstract]   [Full Text] [Related]  

  • 58. Myth: interpretation of a single ammonia level in patients with chronic liver disease can confirm or rule out hepatic encephalopathy.
    Arora S; Martin CL; Herbert M
    CJEM; 2006 Nov; 8(6):433-5. PubMed ID: 17209493
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases.
    ;
    J Hepatol; 2014 Sep; 61(3):642-59. PubMed ID: 25015420
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment in the patient with hepatic encephalopathy and coma].
    Uribe M; Márquez MA; Farca A; Moreno J; Ballesteros A; Marín E
    Rev Gastroenterol Mex; 1982; 47(3):155-63. PubMed ID: 6152568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.